Viewing Study NCT01920295


Ignite Creation Date: 2025-12-24 @ 2:01 PM
Ignite Modification Date: 2025-12-27 @ 9:26 PM
Study NCT ID: NCT01920295
Status: COMPLETED
Last Update Posted: 2013-08-09
First Post: 2013-05-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy of Cryoballoon Ablation of Atrial Fibrillation as First-line Therapy
Sponsor: Yuksek Ihtisas Hospital
Organization:

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2013-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: C-frost
Brief Summary: Cryoballoon ablation of paroxysmal atrial fibrillation can be used as first-line therapy compared to second choice after failed medical therapy
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: